Understanding Surgi-ORC®: From Haemostasis to Antibacterial Activity
Effective bleeding control and wound management are crucial for promoting tissue repair and lowering the risk of surgical complications. While haemostasis is important for controlling bleeding, microbial contamination may delay wound healing, prolong inflammation, and raise the risk of wound-related complications. Common pathogens, including Pseudomonas aeruginosa, Acinetobacter baumannii, and Staphylococcus aureus , can contaminate surgical wounds, impair healing, and contribute to surgical site infections (SSIs).1,2 SSIs remain a significant global healthcare concern, particularly in low- and middle-income countries. 1–3 The growing challenge of antimicrobial resistance can complicate infection management, underscoring the need for effective infection-control strategies to reduce the risk of SSIs. These challenges have raised interest in haemostatic agents with antimicrobial properties that may help address both bleeding and microbial burden. One such approach is Surgi-ORC®, a...